Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence

BACKGROUND AND AIM: The number of longitudinal studies on cognitive functions in patients on buprenorphine-based agonist treatment is limited. Our objective was to assess the change in neurocognitive functions over the first 6 months of buprenorphine-naloxone (BNX) treatment for opioid dependence (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Abhishek, Mahintamani, Tathagata, Rana, Devender K., Basu, Debasish, Mattoo, Surendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045353/
https://www.ncbi.nlm.nih.gov/pubmed/35494328
http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_792_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045353/
https://www.ncbi.nlm.nih.gov/pubmed/35494328
http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_792_21

Ejemplares similares